Optimizing reconstruction parameters for quantitative ¹²⁴ I-PET in the presence of therapeutic doses of ¹³¹ I.

Autor: Fanchon LM; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA., Beattie BJ; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA., Pentlow K; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA., Larson SM; Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA., Humm JL; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA. hummj@mskcc.org.

Publikováno v: EJNMMI physics [EJNMMI Phys] 2021 Jul 12; Vol. 8 (1), pp. 50. Date of Electronic Publication: 2021 Jul 12.

Developments in ¹⁷⁷Lu-based radiopharmaceutical therapy and dosimetry.

Autor: George, Siju C.^1,2, Samuel, E. James Jebaseelan² ejames@vit.ac.in, Lahiri, Susanta³, Haojun Chen⁴, Qinghe Wu⁵

Publikováno v: Frontiers in Chemistry. 2024, p01-13. 13p.

DISTRIBUTION AND RETENTION OF ³⁵S-SODIUM SULFATE IN MAN.

Autor: Woodard, H. Q., Pentlow, K. S., Mayer, K., Laughlin, J. S., Marcove, R. C.

Publikováno v: JNM; Apr1976, Vol. 17 Issue 4, p285-289, 5p, 3 Charts

Risk of treatment-altering haematological toxicity and its dependence on bone marrow doses in peptide receptor radionuclide therapy.

Autor: Persson, Märta¹ (AUTHOR), Hindorf, Cecilia^2,3 (AUTHOR), Ardenfors, Oscar^2,4 (AUTHOR), Larsson, Martin^3,5 (AUTHOR), Nilsson, Joachim N.^2,3 (AUTHOR) joachim.nilsson@ki.se

Publikováno v: EJNMMI Research. 2/6/2024, Vol. 14 Issue 1, p1-10. 10p.

Application of pet radionuclides for nuclear medicine targeted therapies.

Autor: Finn, R. D., Macapinlac, H., Humm, J., Pentlow, K., McDevitt, M., Tjuvajev, J., Blasberg, R., Scheinberg, D., Larson, S., Zweit, J.

Publikováno v: AIP Conference Proceedings; Feb1997, Vol. 392 Issue 1, p1345-1348, 4p